• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

NSC109268以一种不依赖p53的方式增强顺铂诱导的细胞死亡。

NSC109268 potentiates cisplatin-induced cell death in a p53-independent manner.

作者信息

Shankar Eswar, Basu Chandreyi, Adkins Brett, Siede Wolfram, Basu Alakananda

机构信息

Department of Molecular Biology and Immunology, University of North Texas, Health Science Center, Fort Worth, Texas, USA.

出版信息

J Mol Signal. 2010 May 10;5:4. doi: 10.1186/1750-2187-5-4.

DOI:10.1186/1750-2187-5-4
PMID:20459745
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2889948/
Abstract

BACKGROUND

Ovarian cancer is the leading cause of death among gynecological cancers. Cisplatin is one of the most effective anticancer drugs used in the treatment of ovarian cancer. Development of resistance to cisplatin limits its therapeutic use. Most of the anticancer drugs, including cisplatin, are believed to kill cancer cells by inducing apoptosis and a defect in apoptotic signaling can contribute to drug resistance. The tumor suppressor protein p53 plays a critical role in DNA damage-induced apoptosis. During a yeast-based drug screening, NSC109268 was identified to enhance cellular sensitivity to cisplatin. The objective of the present study is to determine if p53 is responsible for cisplatin sensitization by NSC109268.

RESULTS

NSC109268 enhanced sensitivity of ovarian cancer 2008 cells and its cisplatin resistant counterpart 2008/C13* cells which express wild-type p53. The potentiation of cisplatin sensitivity by NSC109268 was greater in 2008/C13* cells compared to 2008 cells. Cisplatin caused a concentration-dependent increase in p53 in 2008 and 2008/C13* cells, and the induction of p53 correlated with cisplatin-induced apoptosis as determined by the cleavage of PARP. NSC109268 alone had no effect on p53 but it enhanced p53 level in response to cisplatin. Knockdown of p53 by siRNA, however, did not attenuate cell death in response to cisplatin or combination of NSC109268 and cisplatin.

CONCLUSIONS

These results demonstrate that NSC109268 enhances sensitivity of ovarian cancer 2008 cells to cisplatin independent of p53.

摘要

背景

卵巢癌是妇科癌症中导致死亡的主要原因。顺铂是治疗卵巢癌最有效的抗癌药物之一。对顺铂产生耐药性限制了其治疗用途。包括顺铂在内的大多数抗癌药物被认为通过诱导细胞凋亡来杀死癌细胞,而凋亡信号传导缺陷可能导致耐药性。肿瘤抑制蛋白p53在DNA损伤诱导的细胞凋亡中起关键作用。在基于酵母的药物筛选过程中,发现NSC109268可增强细胞对顺铂的敏感性。本研究的目的是确定p53是否是NSC109268使顺铂增敏的原因。

结果

NSC109268增强了表达野生型p53的卵巢癌2008细胞及其顺铂耐药对应细胞2008/C13细胞对顺铂的敏感性。与2008细胞相比,NSC109268对2008/C13细胞顺铂敏感性的增强作用更大。顺铂导致2008和2008/C13*细胞中p53浓度依赖性增加,并且p53的诱导与通过PARP裂解确定的顺铂诱导的细胞凋亡相关。单独的NSC109268对p53没有影响,但它增强了顺铂作用下的p53水平。然而,通过小干扰RNA敲低p53并没有减弱顺铂或NSC109268与顺铂联合作用诱导的细胞死亡。

结论

这些结果表明,NSC109268增强卵巢癌2008细胞对顺铂的敏感性,且不依赖于p53。

相似文献

1
NSC109268 potentiates cisplatin-induced cell death in a p53-independent manner.NSC109268以一种不依赖p53的方式增强顺铂诱导的细胞死亡。
J Mol Signal. 2010 May 10;5:4. doi: 10.1186/1750-2187-5-4.
2
Enhancement of cisplatin sensitivity by NSC109268 in budding yeast and human cancer cells is associated with inhibition of S-phase progression.在芽殖酵母和人类癌细胞中,NSC109268 增强顺铂敏感性与 S 期进程抑制有关。
Cancer Chemother Pharmacol. 2010 Oct;66(5):945-52. doi: 10.1007/s00280-010-1246-8. Epub 2010 Jan 26.
3
Rad5 template switch pathway of DNA damage tolerance determines synergism between cisplatin and NSC109268 in Saccharomyces cerevisiae.Rad5 模板转换途径的 DNA 损伤容忍决定了顺铂和 NSC109268 在酿酒酵母中的协同作用。
PLoS One. 2013 Oct 10;8(10):e77666. doi: 10.1371/journal.pone.0077666. eCollection 2013.
4
Over-expression of PTEN sensitizes human ovarian cancer cells to cisplatin-induced apoptosis in a p53-dependent manner.PTEN的过表达使人类卵巢癌细胞以p53依赖的方式对顺铂诱导的凋亡敏感。
Gynecol Oncol. 2006 Aug;102(2):348-55. doi: 10.1016/j.ygyno.2005.12.033. Epub 2006 Mar 20.
5
Cisplatin alters nitric oxide synthase levels in human ovarian cancer cells: involvement in p53 regulation and cisplatin resistance.顺铂改变人卵巢癌细胞中一氧化氮合酶水平:参与p53调控及顺铂耐药
Br J Cancer. 2008 Jun 3;98(11):1803-9. doi: 10.1038/sj.bjc.6604375. Epub 2008 May 27.
6
Ovarian cancer cisplatin-resistant cell lines: multiple changes including collateral sensitivity to Taxol.卵巢癌顺铂耐药细胞系:包括对紫杉醇的旁系敏感性在内的多种变化。
Ann Oncol. 1998 Apr;9(4):423-30. doi: 10.1023/a:1008265012435.
7
Sensitization of p53-mutated epithelial ovarian cancer to CD95-mediated apoptosis is synergistically induced by cisplatin pretreatment.顺铂预处理可协同诱导p53突变的上皮性卵巢癌对CD95介导的细胞凋亡的敏感性。
Mol Cancer Ther. 2007 Feb;6(2):762-72. doi: 10.1158/1535-7163.MCT-06-0357.
8
PACT cessation overcomes ovarian cancer cell chemoresistance to cisplatin by enhancing p53-mediated apoptotic pathway.PACT 阻断可通过增强 p53 介导的凋亡途径克服卵巢癌细胞对顺铂的化疗耐药性。
Biochem Biophys Res Commun. 2019 Apr 16;511(4):719-724. doi: 10.1016/j.bbrc.2019.02.089. Epub 2019 Mar 1.
9
[Relationship between the Akt-regulated direct p53 mitochondrial translocation and the resistance to cisplatin of ovarian cancer cells].Akt 调控的 p53 直接线粒体易位与卵巢癌细胞顺铂耐药性之间的关系
Zhonghua Zhong Liu Za Zhi. 2011 Feb;33(2):97-100.
10
Cisplatin induced apoptosis of ovarian cancer A2780s cells by activation of ERK/p53/PUMA signals.顺铂通过激活ERK/p53/PUMA信号通路诱导卵巢癌A2780s细胞凋亡。
Histol Histopathol. 2018 Jan;33(1):73-79. doi: 10.14670/HH-11-889. Epub 2017 Mar 13.

引用本文的文献

1
Rad5 template switch pathway of DNA damage tolerance determines synergism between cisplatin and NSC109268 in Saccharomyces cerevisiae.Rad5 模板转换途径的 DNA 损伤容忍决定了顺铂和 NSC109268 在酿酒酵母中的协同作用。
PLoS One. 2013 Oct 10;8(10):e77666. doi: 10.1371/journal.pone.0077666. eCollection 2013.
2
Functions of MDMX in the modulation of the p53-response.MDMX在p53反应调节中的功能。
J Biomed Biotechnol. 2011;2011:876173. doi: 10.1155/2011/876173. Epub 2011 Mar 22.

本文引用的文献

1
Enhancement of cisplatin sensitivity by NSC109268 in budding yeast and human cancer cells is associated with inhibition of S-phase progression.在芽殖酵母和人类癌细胞中,NSC109268 增强顺铂敏感性与 S 期进程抑制有关。
Cancer Chemother Pharmacol. 2010 Oct;66(5):945-52. doi: 10.1007/s00280-010-1246-8. Epub 2010 Jan 26.
2
Cell death pathways in response to antitumor therapy.抗肿瘤治疗中的细胞死亡途径。
Tumori. 2009 Jul-Aug;95(4):409-21. doi: 10.1177/030089160909500401.
3
Tumour suppression by p53: a role for the DNA damage response?
p53介导的肿瘤抑制作用:DNA损伤反应起作用吗?
Nat Rev Cancer. 2009 Oct;9(10):714-23. doi: 10.1038/nrc2716. Epub 2009 Sep 4.
4
The genetics of the p53 pathway, apoptosis and cancer therapy.p53信号通路、细胞凋亡与癌症治疗的遗传学
Nat Rev Drug Discov. 2008 Dec;7(12):979-87. doi: 10.1038/nrd2656.
5
The resurgence of platinum-based cancer chemotherapy.基于铂的癌症化疗的复兴。
Nat Rev Cancer. 2007 Aug;7(8):573-84. doi: 10.1038/nrc2167. Epub 2007 Jul 12.
6
Downregulation of Bid is associated with PKCepsilon-mediated TRAIL resistance.Bid的下调与PKCε介导的TRAIL抗性相关。
Cell Death Differ. 2007 Apr;14(4):851-60. doi: 10.1038/sj.cdd.4402077. Epub 2006 Dec 22.
7
Gene expression response to cisplatin treatment in drug-sensitive and drug-resistant ovarian cancer cells.
Oncogene. 2007 May 3;26(20):2860-72. doi: 10.1038/sj.onc.1210086. Epub 2006 Oct 30.
8
Cellular processing of platinum anticancer drugs.铂类抗癌药物的细胞处理过程。
Nat Rev Drug Discov. 2005 Apr;4(4):307-20. doi: 10.1038/nrd1691.
9
Copper transporters regulate the cellular pharmacology and sensitivity to Pt drugs.铜转运蛋白调节细胞药理学以及对铂类药物的敏感性。
Crit Rev Oncol Hematol. 2005 Jan;53(1):13-23. doi: 10.1016/j.critrevonc.2004.09.007.
10
Cisplatin rapidly down-regulates its own influx transporter hCTR1 in cultured human ovarian carcinoma cells.顺铂可迅速下调培养的人卵巢癌细胞中其自身的内流转运体hCTR1。
Clin Cancer Res. 2004 Oct 1;10(19):6744-9. doi: 10.1158/1078-0432.CCR-04-0748.